Hormone Therapy

Testosterone and aging male, a perspective from a developing country.

TL;DR

TRT holds promise as a treatment for hypogonadism, but its implementation and accessibility face significant challenges in a developing country, requiring raised awareness, resource allocation, and cost-effective solutions.

Key Findings

Hypogonadism is associated with a wide range of physical and psychological symptoms affecting overall male health.

  • The condition impacts multiple dimensions of men's health across age groups.
  • Symptoms span both physical and psychological domains.
  • The review used a comprehensive literature review of published peer-reviewed articles to evaluate the condition's impact on ageing males.

Testosterone replacement therapy has been shown to be an effective treatment for hypogonadism, particularly in symptomatic men with low testosterone levels.

  • TRT offers potential benefits including improvements in symptoms and overall quality of life.
  • Effectiveness was evaluated through analysis of published peer-reviewed articles.
  • The therapy is specifically noted to be most relevant for symptomatic men with confirmed low testosterone levels.

TRT is associated with risks and side effects that need to be considered alongside its benefits.

  • The review identified associated risks and side effects as important considerations in TRT use.
  • No specific adverse events were quantified in the abstract, but risks were flagged as a necessary part of clinical decision-making.
  • The balance of benefits and risks was assessed through analysis of existing peer-reviewed literature.

Developing countries face several specific challenges in the diagnosis and treatment of hypogonadism.

  • Identified challenges include lack of awareness and understanding of the condition among healthcare providers and patients.
  • Limited resources and high cost of treatment are significant barriers.
  • These challenges pose additional barriers to accessing TRT and comprehensive care beyond those faced in developed countries.

Addressing awareness, resource allocation, and cost-effectiveness is identified as crucial for improving hypogonadism management in developing countries.

  • Raising awareness among both healthcare providers and patients was highlighted as a key need.
  • Allocating resources and finding cost-effective solutions were identified as necessary steps.
  • Further research and efforts are needed to optimize the potential benefits of TRT for affected individuals in developing country settings.

Have a question about this study?

Citation

Nguyen Hoai B, Hoang L, Nguyen Cao T, Pham Minh Q, A Jannini E. (2023). Testosterone and aging male, a perspective from a developing country.. The aging male : the official journal of the International Society for the Study of the Aging Male. https://doi.org/10.1080/13685538.2023.2223712